Programm                 "Degeneration und Regeneration– Grundlagen, Diagnostik und Therapie"


Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
DOG Information
   DOG Information
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Ablauf der Tagung 2003
   General overview of congress
Lageplan der Räumlichkeiten
   Map of Congress Center
Wissenschaftliche Themen
   Scientific topics
Symposien
   Symposia
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Accompanying program
Arbeitssitzungen
   Working sessions
Rahmenprogramm
   Social program
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Industrieaussteller
   Commercial exhibitors
Sponsoren
   Sponsors
Impressum



DOG Homepage


Abstract
Abstract

Ocular Hypertension: To treat or not to treat?

Pfeiffer N.
Department of Ophthalmology, Mainz University, Germany

Ocular hypertension is defined as elevated intraocular pressure (IOP) in the absence of glaucomatous visual field or optic disc damage. Ocular hypertension may progress to glaucoma. So far, there is disagreement wether or not prophylactic treatment of ocular hypertension by means of lowering IOP is warranted. Two large multicenter studies investigated this question, namely the Ocular Hypertension Treatment Study (OHTS) and the European Glaucoma Prevention Study (EGPS). The EGPS has finished recruitment but has not been terminated. Results from the OHTS demonstrate after 60 months of follow-up a cumulative probability of developing glaucoma in the observation group to be 9.5% versus 4.4% in the medication group. An analysis of baseline factors revealed older age, large vertical or horizontal cup-disc-ratio, higher IOP and thinner central corneal measurements as significant predictors for the development of glaucoma.
The conversion rate from ocular hypertension to glaucoma may be higher than previously assumed. However, more than 90% of ocular hypertensive patients did not convert within five years. Additional risk factors should be considered before initiating therapy in any given patient.


Zurück | Back